The Economic Times

India largely shielded from US tariffs on patented drugs due to generic export strength: GTRI

New US tariffs on patented drugs will not significantly impact India. The country mainly exports affordable generic medicines to America. These generics are currently exempt from the tariffs. Indian firms producing specialized drugs or inputs for patented medicines may face pressure. Future uncertainty exists if tariffs extend to generics.